The implanted tumor interacts with the organ’s native stroma, vasculature, extracellular matrix, and local signaling environment. These interactions help determine whether the tumor becomes established and how it progresses within that tissue. Because the model preserves these site-specific relationships, investigators can examine tumor behavior in an anatomical setting that more closely reflects the corresponding disease in patients.
The native organ provides tissue-specific conditions that can affect tumor biology, local invasion, metastasis, and treatment response. Its structural and signaling features may produce effects that are not represented when tumors grow at nonnative sites. Maintaining this local context therefore helps researchers distinguish responses associated with the tumor itself from those shaped by its surrounding tissue.
Orthotopic engraftment places cancer cells or tumor tissue in the anatomically corresponding organ, whereas a nonnative-site model does not preserve that organ-specific setting. The orthotopic approach retains interactions with local stroma, vasculature, extracellular matrix, and signaling factors. As a result, it can reveal tissue-specific tumor behavior and therapeutic effects that nonnative models may miss.
Orthotopic xenograft models and patient-derived tumor models provide complementary ways to investigate cancer in an organ-matched setting. Both can support studies of tumor establishment, progression, local invasion, metastasis, and therapeutic response. Their value comes from combining the implanted tumor material with the native tissue context, allowing researchers to evaluate behavior under more disease-relevant anatomical conditions.
A basic workflow begins by selecting cancer cells or tumor tissue and implanting that material into the corresponding organ of a model organism. The engrafted material is then studied as it interacts with the organ’s native microenvironment and progresses over time. Researchers can subsequently evaluate tumor biology, invasion, metastasis, or response to an anticancer treatment.
Researchers may choose this approach when the anatomical context could influence the question being studied. It is particularly relevant for examining local invasion, metastasis, tumor progression, and therapeutic response. The models also support preclinical evaluation of anticancer treatments by capturing tissue-specific effects that might not appear when tumors are established outside their corresponding organ.